rethinkTHC Search
Menu
Study breakdown

Placebo Effects May Explain Much of CBD's Reported Benefits for Stress

Clinical TrialModerate evidence
The takeaway

In a three-arm RCT comparing low-dose CBD oil, placebo oil, and no treatment, placebo effects accounted for a significant portion of the improvements attributed to CBD.

CBD consumers, healthcare providers advising on CBD use, and researchers studying cannabinoid therapeutics and placebo effects.

What the researchers found

Both CBD and placebo oil groups showed improvements over the no-treatment control, suggesting that expectation and the ritual of taking a substance contribute significantly to perceived CBD benefits for stress.

Why it matters

CBD products are widely marketed for stress relief, but this study suggests the act of taking something — rather than CBD itself — may drive much of the benefit. This has major implications for consumer expectations and regulatory claims.

The numbers in context

30-day trial with three groups: CBD oil (10% full-spectrum), placebo oil, and no-treatment control. Registered as DRKS00030971.

How the study worked

Three-arm randomized controlled trial comparing 30 days of daily sublingual low-dose (10%) full-spectrum CBD oil vs. placebo oil vs. no-treatment control in stressed university students.

What this study cannot tell us

Low dose may have been insufficient for pharmacological effect. Student sample limits generalizability. 30-day duration may not capture longer-term effects.

How to read the evidence

Well-designed RCT with both placebo and no-treatment controls — strong methodology, though limited by low dose and specific population.

When this study was published

Recent RCT addressing a critical gap in CBD research by including a no-treatment control alongside placebo.

The bigger picture

The CBD market is worth billions, largely built on reported benefits that may be substantially driven by placebo effects. Rigorous trials like this help separate pharmacological reality from expectation-driven outcomes.

Questions still open

  • Would higher CBD doses show clearer separation from placebo? How much of the commercial CBD market's perceived value is driven by placebo and expectation effects?

Common questions

Does this mean CBD doesn't work for stress?
Not necessarily — it means that at this low dose, much of the improvement was also seen with placebo. Higher doses or different formulations might show clearer pharmacological effects.
Why is a no-treatment group important?
Without it, you can't distinguish between improvement from the substance and improvement from simply believing you're being treated. The no-treatment group shows how much natural recovery occurs without any intervention.

Read the original research

Placebo effects in a RCT assessing 30 days of low dose Cannabidiol (CBD) treatment for psychological distress in stressed students at risk for depression.

Journal of cannabis research, 7(1), 98

Citation

Winkler, Alexander; Meis, Annelie C; Hermann, Christiane. (2025). Placebo effects in a RCT assessing 30 days of low dose Cannabidiol (CBD) treatment for psychological distress in stressed students at risk for depression.. Journal of cannabis research, 7(1), 98. https://doi.org/10.1186/s42238-025-00366-9

Explore the wider topic